Trilogy Capital’s Schwab Fundamental US Small Company Index ETF FNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.7M Buy
622,642
+1,953
+0.3% +$69.7K 0.92% 26
2026
Q1
$20.1M Sell
620,689
-116,407
-16% -$3.9M 0.89% 27
2025
Q4
$23.2M Sell
737,096
-8,999
-1% -$281K 1.04% 27
2025
Q3
$23.2M Sell
746,095
-31,542
-4% -$958K 1.07% 21
2025
Q2
$22.3M Buy
777,637
+3,331
+0.4% +$90.4K 1.08% 25
2025
Q1
$21.2M Sell
774,306
-523,121
-40% -$15.3M 1.11% 24
2024
Q4
$38.5M Sell
1,297,427
-10,159
-0.8% -$310K 1.98% 16
2024
Q3
$38.9M Buy
1,307,586
+41,098
+3% +$1.18M 1.96% 14
2024
Q2
$34.8M Buy
1,266,488
+64,370
+5% +$1.78M 1.89% 14
2024
Q1
$34.3M Buy
+1,202,118
New +$32.8M 1.97% 14

Other funds holding FNDA

Trilogy Capital's FNDA Position: Q2 2026 in Review

Trilogy Capital increased its Schwab Fundamental US Small Company Index ETF (FNDA) stake by 0.31% in Q2 2026, buying an estimated $69.7K and bringing the position to 622,642 shares worth $23.7M. The position accounts for 0.92% of the portfolio, ranked #26.

Trilogy Capital first reported a position in FNDA in Q1 2024 and has held it in 10 quarters since. The position peaked at $38.9M in Q3 2024. 483 funds tracked by Wall St. Rank hold FNDA as of Q2 2026.

  • Trilogy Capital held 622,642 shares of Schwab Fundamental US Small Company Index ETF worth $23.7M as of Q2 2026.
  • Trilogy Capital bought 1,953 Schwab Fundamental US Small Company Index ETF shares in Q2 2026, an estimated $69.7K.
  • Schwab Fundamental US Small Company Index ETF made up 0.92% of Trilogy Capital's portfolio in Q2 2026, its #26 holding.
  • Trilogy Capital first reported a position in Schwab Fundamental US Small Company Index ETF in Q1 2024 and has held it in 10 quarters since.
  • Trilogy Capital's Schwab Fundamental US Small Company Index ETF position peaked at $38.9M in Q3 2024.
  • 483 funds tracked by Wall St. Rank held Schwab Fundamental US Small Company Index ETF as of Q2 2026.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.